BRIEF-Txcell announces FDA acceptence of IND for Ovasave
June 29, 2015 at 12:17 PM EDT
* This grants Txcell option of extending current phase 2b CATS29 study from EU to US
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.